EDT vs. MDNA, ONC, SVA, HLS, CRDL, TH, MBX, HBP, CWEB, and HTL
Should you be buying Spectral Medical stock or one of its competitors? The main competitors of Spectral Medical include Medicenna Therapeutics (MDNA), Oncolytics Biotech (ONC), Sernova (SVA), HLS Therapeutics (HLS), Cardiol Therapeutics (CRDL), Theratechnologies (TH), Microbix Biosystems (MBX), Helix BioPharma (HBP), Charlotte's Web (CWEB), and Hamilton Thorne (HTL). These companies are all part of the "medical" sector.
Medicenna Therapeutics (TSE:MDNA) and Spectral Medical (TSE:EDT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, earnings, valuation, profitability, community ranking, media sentiment and dividends.
7.9% of Medicenna Therapeutics shares are held by institutional investors. Comparatively, 13.2% of Spectral Medical shares are held by institutional investors. 23.7% of Medicenna Therapeutics shares are held by company insiders. Comparatively, 20.5% of Spectral Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Spectral Medical has higher revenue and earnings than Medicenna Therapeutics. Spectral Medical is trading at a lower price-to-earnings ratio than Medicenna Therapeutics, indicating that it is currently the more affordable of the two stocks.
Medicenna Therapeutics has a beta of 1.16, indicating that its share price is 16% more volatile than the S&P 500. Comparatively, Spectral Medical has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500.
In the previous week, Medicenna Therapeutics' average media sentiment score of 0.68 beat Spectral Medical's score of 0.00 indicating that Spectral Medical is being referred to more favorably in the news media.
Spectral Medical received 43 more outperform votes than Medicenna Therapeutics when rated by MarketBeat users. However, 68.22% of users gave Medicenna Therapeutics an outperform vote while only 65.17% of users gave Spectral Medical an outperform vote.
Spectral Medical's return on equity of -59.47% beat Medicenna Therapeutics' return on equity.
Summary
Medicenna Therapeutics and Spectral Medical tied by winning 6 of the 12 factors compared between the two stocks.
Get Spectral Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for EDT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding EDT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Spectral Medical Competitors List
Related Companies and Tools
